HomeOwner Search
Visit USCO2020
Category SearchOptimization of Survivin Dimerization Inhibitors for the Treatment of Docetaxel-Resistant Prostate Cancer
Text Registration
Copyright Title
Optimization of Survivin Dimerization Inhibitors for the Treatment of Docetaxel-Resistant Prostate Cancer
Status
Published
on 19 Mar 2020
Year of Creation
2020
Copyright Claimant
Robert Craig Peery
Registration Number
TX0008858433
on 19 Mar 2020Copyright Summary
The U.S. Copyright record (Registration Number: TX0008858433) dated 19 Mar 2020, pertains to an electronic file (eService) titled "Optimization of Survivin Dimerization Inhibitors for the Treatment of Docetaxel-Resistant Prostate Cancer" created in 2020. The copyright holder is Robert Craig Peery, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Robert Craig Peery.
Application Details
Registration Number
TX0008858433
Registration Date
3/19/2020
Year of Creation
2020
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com
Statements
Application Title Statement: Optimization of Survivin Dimerization Inhibitors for the Treatment of Docetaxel-Resistant Prostate Cancer
Author Statement: Robert Craig Peery Citizenship: not known Authorship: text
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.